In transgenic mouse models, overexpression of each of these individual LPA receptors (LPAR1, LPAR2 and LPAR3) under the control of the mouse mammary tumour virus long terminal repeat (MMTV-LTR) promoter led to the formation of late-onset mammary carcinomas [46]. Here, LPAR2 is linked to breast carcinoma.